Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The pharmaceutical company marks the highest increase of the Parisian flagship index while the market trends negatively. The stock is advancing as som…
Sanofi launches on Thursday Action 2026, its global share purchase plan reserved for employees, which is open to approximately 75,000 collaborators ac…
Sanofi announces the integration of Biogen into accelRare, a free pre-diagnostic tool for rare diseases co-developed with 13 Rare Disease Health Netwo…
In the mid-afternoon, the pharmaceutical company is making no progress while the Paris stock market shows significant gains. The stock continues to su…
On Thursday, the FDA granted a priority review for the approval of venglustat to treat type 3 Gaucher's disease in the United States. If approved, thi…
Sanofi shares rise by 1.77% to €76.53 mid-session, as the CAC 40 gains 0.73%. The company is among the top performers on the CAC 40 following the posi…
Sanofi announced on Monday the results of the phase 2 ElevAATe study evaluating efdoralprin alfa, an experimental treatment for patients with emphysem…
Sanofi shares fell by 1.04% to €72.46 in mid-morning trading, after hitting €71.73 during the session, marking a new six-year low. This level surpasse…
Sanofi shares fell by 0.92% to €73.06 in mid-afternoon trading. During the session, the stock touched €72.78, a new low since the 2020 Covid-19 crash …
On Tuesday, Sanofi shares recorded a new six-year low during the session, dropping to €74.21, a level not seen since the Covid-19 crash of 2020. By mi…
